|
|
|
1-10 employees
View all
|
|
pharmaceuticals
|
|
12760 High Bluff Dr,San Diego,California,US
|
|
Viriom Inc. is a commercial and late development stage biotech company developing novel therapies and prevention treatments against HIV and hepatitis B virus (HBV). Viriom's pipeline includes: Elpida® (elsulfavirine), the best-in-class NNRTI that received its first market authorization in 2017; fixed doze combinations with nucleoside reverse transcriptase inhibitors; an innovative extended release weekly oral formulation; and VM1500A - a long acting injectable therapy and pre-exposure prophylaxis. Viriom is also developing a highly potent prodrug of the antiviral tenofovir (active component of both Vemlidy® and Viread®) to treat HIV and hepatitis B patients. Viriom believes its drug candidates are capable of achieving breakthroughs in treatment and prevention of HIV and chronic HBV infections in both developing and developed countries.
|
Viriom Inc Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75%
|
The widely used Viriom Inc email format is {f}{last} (e.g. [email protected]) with 75% adoption across the company.
To contact Viriom Inc customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.